B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor alpha antagonists: differential effects between good and poor clinical responders.

MLA

La, D. T., et al. “B Lymphocyte Stimulator Expression in Patients with Rheumatoid Arthritis Treated with Tumour Necrosis Factor Alpha Antagonists: Differential Effects between Good and Poor Clinical Responders.” Annals of the Rheumatic Diseases, vol. 67, no. 8, Aug. 2008, pp. 1132–38. EBSCOhost, https://doi.org/10.1136/ard.2007.079954.

APA

La, D. T., Collins, C. E., Yang, H.-T., Migone, T.-S., & Stohl, W. (2008). B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor alpha antagonists: differential effects between good and poor clinical responders. Annals of the Rheumatic Diseases, 67(8), 1132–1138. https://doi.org/10.1136/ard.2007.079954

Chicago

La, D T, C E Collins, H-T Yang, T-S Migone, and W Stohl. 2008. “B Lymphocyte Stimulator Expression in Patients with Rheumatoid Arthritis Treated with Tumour Necrosis Factor Alpha Antagonists: Differential Effects between Good and Poor Clinical Responders.” Annals of the Rheumatic Diseases 67 (8): 1132–38. doi:10.1136/ard.2007.079954.